LSP-249
Modify Date: 2025-08-27 17:55:57
LSP-249 structure
|
Common Name | LSP-249 | ||
|---|---|---|---|---|
| CAS Number | 1801253-04-2 | Molecular Weight | 431.92 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H22ClN5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LSP-249LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1]. |
| Name | LSP-249 |
|---|
| Description | LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1]. |
|---|---|
| Related Catalog | |
| Target |
EC50：< 100 nM (kallikrein in cell)[1]. |
| References |
[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1. |
| Molecular Formula | C24H22ClN5O |
|---|---|
| Molecular Weight | 431.92 |
| InChIKey | BDLURRLRBKLEDL-UHFFFAOYSA-N |
| SMILES | Cc1cc(N)nc(C)c1CNC(=O)c1ccnc(Cc2ccc3ncc(Cl)cc3c2)c1 |
| Storage condition | -20°C |